Author:
Phernambucq Erik C.J.,Palma David A.,Vincent Andrew,Smit Egbert F.,Senan Suresh
Subject
Cancer Research,Pulmonary and Respiratory Medicine,Oncology
Reference19 articles.
1. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer;Auperin;J Clin Oncol,2010
2. Phase III trial of maintenance gefitinib or placebo after concurrent chemoradiotherapy and docetaxel consolidation in inoperable stage III non-small-cell lung cancer: SWOG S0023;Kelly;J Clin Oncol,2008
3. Radiation Therapy Oncology Group. A randomized phase III comparison of standard-dose (60Gy) versus highdose (74Gy) conformal radiotherapy with concurrent and consolidation carboplatin/paclitaxel +/− cetuximab (IND #103444) in patients with stage IIIA/IIIB non-small cell lung cancer. RTOG 0617/NCCTG N0628/CALGB 30609/ECOG R0617. Study protocol available online at: http://www.rtog.org/ClinicalTrials/ProtocolTable/StudyDetails.aspx?study=0617 [last accessed 07.03.2011].
4. A randomized phase II study comparing induction or consolidation chemotherapy with cisplatin-docetaxel, plus radical concurrent chemoradiotherapy with cisplatin-docetaxel, in patients with unresectable locally advanced non-small-cell lung cancer;Senan;Ann Oncol,2011
5. Concurrent chemoradiotherapy in non-small cell lung cancer;O’Rourke;Cochrane Database Syst Rev,2010